Half a Million Reasons to Hope

Indivior's Commitment to Powering Recovery

Building on Indivior's 25-year legacy, we are reaffirming our commitment to improving the lives of individuals with opioid use disorder (OUD). As of April 2026, 500,000+ people have been prescribed our long-acting injectable buprenorphine treatment for OUD.

This number symbolizes the half-million patients and families who are taking steps towards meaningful recovery. Behind every prescription is a person, their community, and a step forward on the path to recovery. It's a parent who can be present again. A friend who watches someone they love find their way back to themselves. A child who can keep their hero.

This reflects an important step in Indivior's continued progress toward expanding access to evidence-based treatment for OUD. And it is a time to reflect on the inspiring work our team has accomplished, and the work still ahead of us.

As part of our recent All-Employee Meeting and in honor of the 500,000 prescriptions milestone, Indivior team members packed 500 support bags for REAL LIFE, an organization creating pathways for individuals transitioning out of jail, living with substance use disorder, or experiencing homelessness.